# Evaluation of MCM5 in Postmenopausal Bleeding Patients

> **NCT05287048** · — · UNKNOWN · sponsor: **Arquer Diagnostics Ltd** · enrollment: 2000 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **DIAGNOSTIC_TEST:** MCM5 ELISA

## Key facts

- **NCT ID:** NCT05287048
- **Lead sponsor:** Arquer Diagnostics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2023-09
- **Final completion:** 2023-09
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2023-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05287048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05287048, "Evaluation of MCM5 in Postmenopausal Bleeding Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05287048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*